Medical Health & Life Science Research News

New study: Global capecitabine market report for 2017

Medical Market Research

The market report, Capecitabine market uses qualitative and quantitative research techniques to showcase competitive landscape for the forecast period, 2017 - 2022. Besides this, the report further blends in primary and secondary research techniques to assess, interpret, the segment as well as forecast the total revenue generated by the industry across various regions. Business owners/stakeholders can chalk-out expansion plan by leveraging statistics on market share, size, sale volume, growth rate and return over-invest discussed in the study.

- Advertisement -
- Upgrade your free trial to remove advertising -

This report is based on the study of the global market for capecitabine. To give a brief description about this chemical compound, it is a prodrug, enzymatically transformed into a fluorouracil in the tumour.

It is orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. In the tumour cells, it inhibits DNA synthesis and slows growth of tumor tissue. 

- Advertisement -
- Upgrade your free trial to remove advertising -

Topics Covered in this Report

The report focuses on the important geographies of sale of the Capecitabine such as North America, Europe and Asia-Pacific, South America, Middle East and Africa. The entire capecitabine market has been categorized into three segments in this report, namely- manufacturers, regions, type and application.

In market segmentation by manufacturers, the report covers the following companies- 

  • Roche
  • Teva
  • Mylan
  • Hikma
  • Hengrui Medicine
  • Cipla, Reliance Group
  • Hetero

In market segmentation by geographical regions, the report has analysed the following regions- 

North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

In market segmentation by types of capecitabines, the report covers-

  • 500 mg
  • 150 mg

Get the Free Sample Copy of Report @
www.reportsanddata.com/sample-enquiry-form/261

In market segmentation by applications of the capecitabine, the report covers the following uses- 

  • Breast Cancer
  • Colorectal cancer
  • Stomach Cancer 

The report is distributed over 15 Chapters to display the analysis of the global Capecitabine market.
Chapter 1 covers the Capecitabine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2 talks about the top manufacturers and analyses their sales, revenue and pricing decisions for the duration 2016 and 2017;

Chapter 3 displays the competitive nature of the market by discussing the competition among the top manufacturers. It dissects the market using sales, revenue and market share data for 2016 and 2017;

Chapter 4, shows the global market by regions and the proportionate size of each market region based on sales, revenue and market share of Capecitabine, for the period 2012- 2017;

Inquire for Complete Report copy [email protected] www.reportsanddata.com/make-enquiry-form/261

News From

Reports and DataReports and Data
Category: Market Research Publishers and RetailersCompany about: Team ‘“Reports and Data”’ united for one reason – to deliver accurate, highly dependable and revealing market insight. Proudly independent, our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help you make a smarter business decision. Group of intellectuals at Reports and Data partner to measure out actionable insights as well as primary and secondary data, thereby lowering risks and augmenting customer del ...